Purpose: To investigate whether ADSC-derived miR-23-enriched exosomes could protect against calcium oxalate stone formation in a hyperoxaluria rat model.

Methods: An ethylene glycol- (EG-) induced hyperoxaluria rat model and an in vitro model of COM-induced HK-2 cells coculturing with RAW264.7 cells were established to explore the protective mechanisms of ADSC-derived miR-23-enriched exosomes.

Results: The results showed that treatment with miR-23-enriched exosomes from ADSCs protected EG-induced hyperoxaluria rats, and cell experiments confirmed that coculturing with miR-23-enriched exosomes alleviated COM-induced cell autophagy. Overexpressed miR-23 suppressed M1 macrophage polarization by inhibiting IRF1 expression. Furthermore, the predicted binding site between the IRF1 messenger RNA 3'-untranslated region (3'-UTR) and miR-23 was confirmed by the dual-luciferase reporter assay.

Conclusion: In conclusion, our research gave the first evidence that ADSC-derived miR-23-enriched exosomes affected the polarization of M1 macrophages by directly inhibiting IRF1 and protecting against calcium oxalate stone formation in a hyperoxaluria rat model.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667050PMC
http://dx.doi.org/10.1155/2023/2883623DOI Listing

Publication Analysis

Top Keywords

hyperoxaluria rat
16
mir-23-enriched exosomes
16
calcium oxalate
12
rat model
12
adsc-derived mir-23-enriched
12
oxalate stone
8
stone formation
8
formation hyperoxaluria
8
inhibiting irf1
8
exosomes
5

Similar Publications

Introduction: Free radical-mediated oxidative renal tubular injury secondary to hyperoxaluria is a proposed mechanism in the formation of calcium oxalate stones. Vitamin E, an important physiologic antioxidant, has been shown in rat models to prevent calcium oxalate crystal deposition. Our objective was to determine if low dietary vitamin E intake was associated with a higher incidence of stones.

View Article and Find Full Text PDF

Empagliflozin reduces renal calcium oxalate deposition in hyperoxaluria rats induced with ethylene glycol-ammonium chloride.

Biochem Biophys Res Commun

December 2024

Guizhou Medical University, No.9 Beijing Road, Yunyan District, Guiyang, Guizhou, China; Department of Urology, Guizhou Provincial People's Hospital, No.83 East Zhongshan Road, Nanming District, Guiyang, Guizhou, China. Electronic address:

A retrospective study reported that empagliflozin reduced the risk of urinary stone events in patients with diabetes mellitus. To further investigate empagliflozin's potential, we conducted an animal experiment to determine whether empagliflozin can prevent renal stone formation in hyperoxaluria rats. Hyperoxaluria rat models were constructed by administrating 0.

View Article and Find Full Text PDF

The Altered Proteomic Landscape in Renal Tubular Epithelial Cells under High Oxalate Stimulation.

Biology (Basel)

October 2024

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Article Synopsis
  • The study investigates how oxalate affects rat renal tubular epithelial cells using a proteomic approach to identify changes in protein expression.
  • It found 268 different proteins that were expressed differently in cells treated with oxalate compared to control cells, highlighting pathways like oxidative stress and inflammation.
  • Certain proteins were identified as potential biomarkers and therapeutic targets, providing insights into preventing kidney damage and kidney stone formation caused by high oxalate levels.
View Article and Find Full Text PDF
Article Synopsis
  • Primary hyperoxaluria type 1 (PH1) is a serious genetic disorder that causes harmful oxalate buildup in organs, especially the kidneys, with the Hao1 gene playing a key role in oxalate production.
  • This study discovered new therapeutic sites in the Hao1 gene and successfully used lipid nanoparticles to deliver adenine base editing (ABE) mRNA, resulting in substantial reduction of the Hao1 gene in the liver and normalization of urinary oxalate levels in PH1 rats for at least 6 months.
  • The results indicate that effective editing of the Hao1 gene is crucial for reducing urinary oxalate, making LNP-mediated base editing a promising and safe treatment option for PH1 in clinical applications.
View Article and Find Full Text PDF

Screening of oxalate-degrading probiotics and preventive effect of AR1089 on kidney stones.

Food Funct

September 2024

Shanghai Engineering Research Center of Food Microbiology, School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.

Calcium oxalate stone is the main type of kidney stone, so far there is no specific drug treatment. Here, we screened for oxalate-degrading probiotics and evaluated the potential preventive effect of lactic acid bacteria in rats with hyperoxaluria-induced kidney stones. The oxalate degradation efficiencies of the probiotics were determined to be 5-20% by experiments, of which the degradation efficiencies of AR342 and AR1089 were 17.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!